340 related articles for article (PubMed ID: 28210120)
1. Single nucleotide polymorphisms as susceptibility, prognostic, and therapeutic markers of nonsmall cell lung cancer.
Zienolddiny S; Skaug V
Lung Cancer (Auckl); 2012; 3():1-14. PubMed ID: 28210120
[TBL] [Abstract][Full Text] [Related]
2. Genetic risk profiles for cancer susceptibility and therapy response.
Bartsch H; Dally H; Popanda O; Risch A; Schmezer P
Recent Results Cancer Res; 2007; 174():19-36. PubMed ID: 17302182
[TBL] [Abstract][Full Text] [Related]
3. Lung cancer susceptibility and prognosis associated with polymorphisms in the nonhomologous end-joining pathway genes: a multiple genotype-phenotype study.
Tseng RC; Hsieh FJ; Shih CM; Hsu HS; Chen CY; Wang YC
Cancer; 2009 Jul; 115(13):2939-48. PubMed ID: 19408343
[TBL] [Abstract][Full Text] [Related]
4. Role of ERCC5 polymorphisms in non‑small cell lung cancer risk and responsiveness/toxicity to cisplatin‑based chemotherapy in the Chinese population.
Li M; Chen R; Ji B; Fan C; Wang G; Yue C; Jin G
Oncol Rep; 2021 Mar; 45(3):1295-1305. PubMed ID: 33469680
[TBL] [Abstract][Full Text] [Related]
5. The role of individual susceptibility in cancer burden related to environmental exposure.
Bartsch H; Hietanen E
Environ Health Perspect; 1996 May; 104 Suppl 3(Suppl 3):569-77. PubMed ID: 8781385
[TBL] [Abstract][Full Text] [Related]
6. Genetic variants of CHEK1, PRIM2 and CDK6 in the mitotic phase-related pathway are associated with nonsmall cell lung cancer survival.
Mu R; Liu H; Luo S; Patz EF; Glass C; Su L; Du M; Christiani DC; Jin L; Wei Q
Int J Cancer; 2021 Sep; 149(6):1302-1312. PubMed ID: 34058013
[TBL] [Abstract][Full Text] [Related]
7. Potentially functional genetic variants in PLIN2, SULT2A1 and UGT1A9 genes of the ketone pathway and survival of nonsmall cell lung cancer.
Tang D; Zhao YC; Liu H; Luo S; Clarke JM; Glass C; Su L; Shen S; Christiani DC; Gao W; Wei Q
Int J Cancer; 2020 Sep; 147(6):1559-1570. PubMed ID: 32072637
[TBL] [Abstract][Full Text] [Related]
8. Human lung carcinogen-DNA adduct levels mediated by genetic polymorphisms in vivo.
Kato S; Bowman ED; Harrington AM; Blomeke B; Shields PG
J Natl Cancer Inst; 1995 Jun; 87(12):902-7. PubMed ID: 7666479
[TBL] [Abstract][Full Text] [Related]
9. Impact of DNA repair, folate and glutathione gene polymorphisms on risk of non small cell lung cancer.
Pérez-Ramírez C; Cañadas-Garre M; Alnatsha A; Villar E; Delgado JR; Calleja-Hernández MÁ; Faus-Dáder MJ
Pathol Res Pract; 2018 Jan; 214(1):44-52. PubMed ID: 29254785
[TBL] [Abstract][Full Text] [Related]
10. Common genetic variation in TP53 is associated with lung cancer risk and prognosis in African Americans and somatic mutations in lung tumors.
Mechanic LE; Bowman ED; Welsh JA; Khan MA; Hagiwara N; Enewold L; Shields PG; Burdette L; Chanock S; Harris CC
Cancer Epidemiol Biomarkers Prev; 2007 Feb; 16(2):214-22. PubMed ID: 17301252
[TBL] [Abstract][Full Text] [Related]
11. Novel genetic variants in KIF16B and NEDD4L in the endosome-related genes are associated with nonsmall cell lung cancer survival.
Yang S; Tang D; Zhao YC; Liu H; Luo S; Stinchcombe TE; Glass C; Su L; Shen S; Christiani DC; Wang Q; Wei Q
Int J Cancer; 2020 Jul; 147(2):392-403. PubMed ID: 31618441
[TBL] [Abstract][Full Text] [Related]
12. Genetic polymorphisms and lung cancer susceptibility: a review.
Kiyohara C; Otsu A; Shirakawa T; Fukuda S; Hopkin JM
Lung Cancer; 2002 Sep; 37(3):241-56. PubMed ID: 12234692
[TBL] [Abstract][Full Text] [Related]
13. Polymorphisms of p53 and MDM2 genes are associated with severe toxicities in patients with non-small cell lung cancer.
Zheng D; Chen Y; Gao C; Wei Y; Cao G; Lu N; Hou Y; Jiang X; Wang J
Cancer Biol Ther; 2014; 15(11):1542-51. PubMed ID: 25482940
[TBL] [Abstract][Full Text] [Related]
14. Functional effect of polymorphisms in 15q25 locus on CHRNA5 mRNA, bulky DNA adducts and TP53 mutations.
Tekpli X; Landvik NE; Skaug V; Gulsvik A; Haugen A; Zienolddiny S
Int J Cancer; 2013 Apr; 132(8):1811-20. PubMed ID: 23011884
[TBL] [Abstract][Full Text] [Related]
15. Markers of genetic susceptibility in human environmental hygiene and toxicology: the role of selected CYP, NAT and GST genes.
Thier R; Brüning T; Roos PH; Rihs HP; Golka K; Ko Y; Bolt HM
Int J Hyg Environ Health; 2003 Jun; 206(3):149-71. PubMed ID: 12872524
[TBL] [Abstract][Full Text] [Related]
16. Genetic Polymorphisms in the Vitamin D Pathway and Non-small Cell Lung Cancer Survival.
Kong J; Chen X; Wang J; Li J; Xu F; Gao S; Yu H; Qian B
Pathol Oncol Res; 2020 Jul; 26(3):1709-1715. PubMed ID: 31625015
[TBL] [Abstract][Full Text] [Related]
17. Differential mutation profiles and similar intronic TP53 polymorphisms in asbestos-related lung cancer and pleural mesothelioma.
Andujar P; Pairon JC; Renier A; Descatha A; Hysi I; Abd-Alsamad I; Billon-Galland MA; Blons H; Clin B; Danel C; Debrosse D; Galateau-Sallé F; Housset B; Laurent-Puig P; Le Pimpec-Barthes F; Letourneux M; Monnet I; Régnard JF; Validire P; Zucman-Rossi J; Jaurand MC; Jean D
Mutagenesis; 2013 May; 28(3):323-31. PubMed ID: 23435014
[TBL] [Abstract][Full Text] [Related]
18. Environmental and chemical carcinogenesis.
Wogan GN; Hecht SS; Felton JS; Conney AH; Loeb LA
Semin Cancer Biol; 2004 Dec; 14(6):473-86. PubMed ID: 15489140
[TBL] [Abstract][Full Text] [Related]
19. Effect of Single Nucleotide Polymorphisms in the Vitamin D Metabolic Pathway on Susceptibility to Non-Small-Cell Lung Cancer.
Pineda Lancheros LE; Rojo Tolosa S; Gálvez Navas JM; Martínez Martínez F; Sánchez Martín A; Jiménez Morales A; Pérez Ramírez C
Nutrients; 2022 Nov; 14(21):. PubMed ID: 36364930
[TBL] [Abstract][Full Text] [Related]
20. Associations of polymorphisms in DNA repair genes and MDR1 gene with chemotherapy response and survival of non-small cell lung cancer.
Du Y; Su T; Zhao L; Tan X; Chang W; Zhang H; Cao G
PLoS One; 2014; 9(6):e99843. PubMed ID: 24933103
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
